IT1275571B - Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori - Google Patents
Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumoriInfo
- Publication number
- IT1275571B IT1275571B ITMI951560A ITMI951560A IT1275571B IT 1275571 B IT1275571 B IT 1275571B IT MI951560 A ITMI951560 A IT MI951560A IT MI951560 A ITMI951560 A IT MI951560A IT 1275571 B IT1275571 B IT 1275571B
- Authority
- IT
- Italy
- Prior art keywords
- photoactivation
- diagnosis
- cancer therapy
- fluorogenic substrates
- enzymatic transformation
- Prior art date
Links
- 238000003745 diagnosis Methods 0.000 title 1
- 230000002255 enzymatic effect Effects 0.000 title 1
- 239000007850 fluorescent dye Substances 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 230000002186 photoactivation Effects 0.000 title 1
- 230000009466 transformation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI951560A IT1275571B (it) | 1995-07-19 | 1995-07-19 | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
CA002227212A CA2227212A1 (en) | 1995-07-19 | 1996-07-19 | Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
PCT/EP1996/003201 WO1997003697A2 (en) | 1995-07-19 | 1996-07-19 | Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
US09/011,347 US6036941A (en) | 1995-07-19 | 1996-07-19 | Fluorogenic substrates for diagnosis and photodynamic treatment of tumors |
EP96927559A EP0839051A1 (en) | 1995-07-19 | 1996-07-19 | Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
AU67351/96A AU6735196A (en) | 1995-07-19 | 1996-07-19 | Fluorogenic substrates for diagnosis and photodynamic treatment of tumours |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI951560A IT1275571B (it) | 1995-07-19 | 1995-07-19 | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI951560A0 ITMI951560A0 (it) | 1995-07-19 |
ITMI951560A1 ITMI951560A1 (it) | 1997-01-19 |
IT1275571B true IT1275571B (it) | 1997-08-07 |
Family
ID=11372009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI951560A IT1275571B (it) | 1995-07-19 | 1995-07-19 | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori |
Country Status (6)
Country | Link |
---|---|
US (1) | US6036941A (it) |
EP (1) | EP0839051A1 (it) |
AU (1) | AU6735196A (it) |
CA (1) | CA2227212A1 (it) |
IT (1) | IT1275571B (it) |
WO (1) | WO1997003697A2 (it) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6493570B1 (en) * | 1998-11-02 | 2002-12-10 | Photogen, Inc. | Method for improved imaging and photodynamic therapy |
US7036516B1 (en) | 1996-10-30 | 2006-05-02 | Xantech Pharmaceuticals, Inc. | Treatment of pigmented tissues using optical energy |
US7390668B2 (en) | 1996-10-30 | 2008-06-24 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for photodynamic treatment of disease |
US6331286B1 (en) * | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
US8974363B2 (en) | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
WO2000007515A1 (en) * | 1998-08-06 | 2000-02-17 | Photogen, Inc. | Improved method for targeted topical treatment of disease |
US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
US7648695B2 (en) | 1998-08-06 | 2010-01-19 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
US20090117199A1 (en) * | 1998-08-06 | 2009-05-07 | Scott Timothy C | Method of treatment of cancer |
US6986740B2 (en) * | 1998-11-02 | 2006-01-17 | Xantech Pharmaceuticals, Inc. | Ultrasound contrast using halogenated xanthenes |
US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
US8470296B2 (en) | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
CA2358662A1 (en) * | 1999-01-15 | 2000-07-20 | James Chen | Therapeutic compositions for metabolic bone disorders or bone metastases |
AU2412800A (en) * | 1999-01-15 | 2000-08-01 | Light Sciences Corporation | Noninvasive vascular therapy |
US6602274B1 (en) * | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
EP1040825A1 (en) * | 1999-03-11 | 2000-10-04 | K.U. Leuven Research & Development | Means for diagnosing bladder carcinoma |
US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
US7166719B2 (en) | 2002-06-27 | 2007-01-23 | Health Research, Inc. | Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
JP2003519670A (ja) * | 2000-01-12 | 2003-06-24 | ライト サイエンシーズ コーポレイション | 眼疾患の新規処置 |
WO2001089584A2 (en) * | 2000-05-23 | 2001-11-29 | Amersham Health As | Contrast agents |
GB0113899D0 (en) | 2001-06-07 | 2001-08-01 | Photocure Asa | Photodynamic therapy lamp |
CA2473924A1 (en) * | 2002-01-23 | 2003-07-31 | Light Sciences Corporation | Systems and methods for photodynamic therapy |
CN1389110A (zh) * | 2002-05-10 | 2003-01-08 | 张红雨 | 苝醌衍生物光敏生物杀菌剂及其制法 |
GB0215534D0 (en) * | 2002-07-04 | 2002-08-14 | Ecole Polytech | Selective photochemotherapy using oligonucleotide targeting agents |
US20050106100A1 (en) * | 2003-09-03 | 2005-05-19 | Harris Thomas D. | Compounds containing matrix metalloproteinase substrates and methods of their use |
US20060067889A1 (en) * | 2004-09-27 | 2006-03-30 | Light Sciences Corporation | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
US20070014721A1 (en) * | 2005-06-30 | 2007-01-18 | Harris Thomas D | Hydrazide conjugates as imaging agents |
CA2633636A1 (en) * | 2005-11-15 | 2007-05-24 | The General Hospital Corporation | Photoactivatable antimicrobial agents |
WO2007072800A1 (ja) * | 2005-12-19 | 2007-06-28 | The University Of Tokyo | 光増感用化合物 |
US9358292B2 (en) * | 2007-04-08 | 2016-06-07 | Immunolight, Llc | Methods and systems for treating cell proliferation disorders |
US20090104212A1 (en) * | 2007-08-06 | 2009-04-23 | Immunolight | Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption |
CL2009000393A1 (es) * | 2008-02-21 | 2010-01-04 | Duke Univ Y Immunolight Llc | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. |
EP2268311A4 (en) * | 2008-04-04 | 2014-08-27 | Immunolight Llc | NON-INVASIVE SYSTEMS AND METHOD FOR PHOTOBIOMODULATION IN SITU |
ES2699376T3 (es) | 2008-05-05 | 2019-02-11 | Massachusetts Gen Hospital | Métodos para usar sustratos enzimáticos marcados con bodipy |
US9042967B2 (en) | 2008-05-20 | 2015-05-26 | University Health Network | Device and method for wound imaging and monitoring |
EP2729175B1 (en) | 2011-07-08 | 2021-12-01 | Duke University | System for light stimulation within a medium |
KR101385196B1 (ko) | 2012-05-17 | 2014-04-14 | 주식회사 유니크메디케어 | 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법 |
US9371555B2 (en) | 2012-06-01 | 2016-06-21 | Concordia Laboratories Inc. | Lighting systems and methods of using lighting systems for in vitro potency assay for photofrin |
US20160073634A1 (en) | 2012-06-22 | 2016-03-17 | The General Hospital Corporation | Beta-lactamase targeted photosensitizer for pesticide and pest detection |
WO2014139012A1 (en) | 2013-03-15 | 2014-09-18 | Suncor Energy Inc. | Herbicidal compositions |
PT3171765T (pt) | 2014-07-24 | 2021-10-27 | Univ Health Network | Recolha e análise de dados para fins diagnósticos |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4647367A (en) * | 1985-12-23 | 1987-03-03 | Uop Inc. | Antifouling agents for prevention of unwanted coke formation in reactors |
FR2611141B1 (fr) * | 1987-02-20 | 1991-02-01 | Int Rech Cancer Centre | Ensemble ou kit pour utilisation comme agent pour la destruction selective de cellules transformees ou tumorales |
US4924009A (en) * | 1987-06-03 | 1990-05-08 | Bowling Green State University | Xanthene dye complexes |
US5137800A (en) * | 1989-02-24 | 1992-08-11 | Stereographics Limited Partnership | Production of three dimensional bodies by photopolymerization |
WO1993014197A1 (en) * | 1992-01-16 | 1993-07-22 | New York University | Hypericin treatment of vaccine agents for improved immunogenicity |
ATE177842T1 (de) * | 1993-09-03 | 1999-04-15 | Behringwerke Ag | Fluoreszenz-sauerstoffkanalisation-immunteste |
-
1995
- 1995-07-19 IT ITMI951560A patent/IT1275571B/it active IP Right Grant
-
1996
- 1996-07-19 EP EP96927559A patent/EP0839051A1/en not_active Withdrawn
- 1996-07-19 US US09/011,347 patent/US6036941A/en not_active Expired - Fee Related
- 1996-07-19 AU AU67351/96A patent/AU6735196A/en not_active Abandoned
- 1996-07-19 CA CA002227212A patent/CA2227212A1/en not_active Abandoned
- 1996-07-19 WO PCT/EP1996/003201 patent/WO1997003697A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ITMI951560A0 (it) | 1995-07-19 |
US6036941A (en) | 2000-03-14 |
WO1997003697A3 (en) | 1997-04-10 |
AU6735196A (en) | 1997-02-18 |
ITMI951560A1 (it) | 1997-01-19 |
WO1997003697A2 (en) | 1997-02-06 |
EP0839051A1 (en) | 1998-05-06 |
CA2227212A1 (en) | 1997-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1275571B (it) | Substrati fluorogenici suscettibili di fotoattivazione previa trasformazione per via enzimatica atti alla diagnosi ed alla terapia fotodinamica dei tumori | |
AU4473596A (en) | Methods of human prostate cancer diagnosis | |
AU7012496A (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
EP0831904A4 (en) | TREATMENT AND DIAGNOSIS OF PROSTATE CANCER | |
AU2189497A (en) | Radiotherapy treatment using medial access transformation | |
AU5481000A (en) | Combination cancer therapy comprising adenosine and deaminase enzyme inhibitor | |
AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
AU2001278083A1 (en) | Procedures for photodynamic cardiac ablation therapy and devices for those procedures | |
AU3792293A (en) | Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors | |
CA2199117A1 (en) | Compounds and methods for the treatment of cancer | |
AU4185100A (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use | |
AU8397998A (en) | Method and apparatus for radiation and hyperthermia therapy of tumors | |
AU2074201A (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
AU7380500A (en) | Methods for treating tumors using neutron therapy | |
ITMI962745A0 (it) | Sonda-catetere per il trattamento di tumori di organi parenchimatosi con ipertermia interstiziale indotta da radiofrequenza | |
AU5300396A (en) | Radiation enhanced gene therapy for treatment of tumors | |
AU6583700A (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
AU2596901A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
AU1395499A (en) | Methods for treatment of tumors and tumor cells using (ex vivo) activated t cells | |
AU2074101A (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
AU6062900A (en) | Substituted indole compounds and their use for the treatment of cancer | |
EP0716614A4 (en) | TREATMENT OF HUMAN TUMORS BY GENETIC TRANSFORMATION OF HUMAN TUMORS | |
AU2001290949A1 (en) | Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma | |
AU4410296A (en) | Diagnosis of and therapy for hereditary haemorrhagic telangiectasia | |
AU3177500A (en) | Proteins for diagnosis and treatment of breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted |